Related Experiment Video
Updated: Jun 22, 2025

05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.6K
A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation
Ananya A Basu1,2, Chenlu Zhang1, Isabella A Riha1
1Department of Chemistry, Northwestern University, Evanston, IL, USA.
Nature Chemical Biology
|July 4, 2024
Summary
Researchers identified a new E3 ligase, F-box protein 22 (FBXO22), to enhance targeted protein degradation (TPD) using proteolysis-targeting chimeras (PROTACs). This discovery expands the toolkit for degrading disease-related proteins.
Area of Science:
- Chemical Biology
- Molecular Biology
- Genetics
Background:
- Targeted protein degradation (TPD) is a powerful method for eliminating specific proteins.
- Expanding the repertoire of E3 ligases is crucial for advancing TPD applications.
- Existing E3 ligases limit the scope of TPD strategies.
Purpose of the Study:
- To identify novel human E3 ligases capable of facilitating heterobifunctional compound-mediated degradation.
- To discover new E3 ligases for proteolysis-targeting chimera (PROTAC) development.
- To validate the utility of identified E3 ligases in degrading various target proteins.
Main Methods:
- A clustered regularly interspaced short palindromic repeats (CRISPR)-based transcriptional activation screen was employed to identify functional E3 ligases.
- A candidate PROTAC, 22-SLF, was designed and tested for its ability to induce target degradation.
- Mechanistic studies investigated the interaction between the PROTAC and the identified E3 ligase.
- The efficacy of FBXO22-based PROTACs was demonstrated against additional endogenous proteins.
Main Results:
- A CRISPR screen identified F-box protein 22 (FBXO22) as a novel E3 ligase for TPD.
- The PROTAC 22-SLF was shown to induce degradation of FK506-binding protein 12 (FKBP12) via FBXO22.
- 22-SLF was found to interact with cysteine residues C227 and/or C228 in FBXO22.
- FBXO22-based PROTACs successfully degraded bromodomain-containing protein 4 (BRD4) and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion protein.
Conclusions:
- FBXO22 is a newly identified E3 ligase that can be leveraged for targeted protein degradation.
- FBXO22-based PROTACs offer a versatile platform for degrading diverse endogenous proteins.
- This work expands the E3 ligase toolbox for developing novel TPD therapeutics.
Related Concept Videos
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
CRISPR
50.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.4K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K

